Skip to main content
. 2015 Apr 11;15:40. doi: 10.1186/s12886-015-0025-z

Figure 1.

Figure 1

Good anatomical response to 3 aflibercept injections in a ranibizumab resistant AMD case. a. PED before intravitreal ranibizumab (VA: 0.8 LogMAR). b: Intense subretinal fluid is observed on OCT despite 24 ranibizumab injections (VA: 2.1 LogMAR). c. Subretinal fluid has completely disappeared after a single aflibercept injection on OCT (VA: 2.1 LogMAR). d. No subretinal fluid is seen after the third aflibercept injection on OCT (VA: 2.1 LogMAR)